What was once the largest announced acquisition in U.S. cannabis history is no more.
News & Analysis: MedMen Enterprises Inc.
Changing industry dynamics are forcing these marijuana companies to scuttle a once-promising combination.
Don't expect these brand-name pot stocks to deliver the green anytime soon.
Two of these three pot stocks are trading below their book value, but that doesn't make them worth buying.
A few popular cannabis stocks aren't the bargains they're made out to be.
A number of marijuana acquisitions are taking longer than expected to close.
Brand-name marijuana stocks don't always make for the best investments.
Which stock wins in a matchup between a leading U.S. cannabis retailer and an up-and-coming Canadian cannabis producer?
One investment bank sees 41% to 96% upside in three popular pot stocks.
Are these pot stocks bargains or value traps?